Sterling Pharma Solutions

📍 Cramlington, United Kingdom🗓 Founded 1969👥 899 employees💰 Last funded May 2023
Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; a Partnership Development and Manufacturing Organisation (PDMO®). Sterling has six facilities across the UK, USA and Europe, employing 1,350+ people, including in Cramlington and Newcastle, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Find out more: www.sterlingpharmasolutions.com/sterling-facilities
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
1969
Founded
Investor geography3 countries
Switzerland
2
United Arab Emirates
1
United Kingdom
1
Investor activity2019–2023 · investors recorded per year
201912020120232
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sterling Pharma Solutions?
Sterling Pharma Solutions has 4 investors on record on gritt.io.
When did Sterling Pharma Solutions last raise funding?
The most recent investment in Sterling Pharma Solutions recorded on gritt.io was in May 2023.
When was Sterling Pharma Solutions founded?
Sterling Pharma Solutions was founded in 1969.
What industry is Sterling Pharma Solutions in?
Sterling Pharma Solutions operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sterling Pharma Solutions based?
Sterling Pharma Solutions is headquartered in Cramlington, United Kingdom.